Michelle Riba, MD, MS, DFAPA, FAPM

Comorbidity: The concept is simple enough, but in practice, comorbidity drives complexity and presents the specters of diagnostic ambiguity and therapeutic unpredictability.

Understanding and developing treatments for the cardiovascular system and how it relates to psychosocial distress and the nervous system are keys to the future of psychiatry.

The next several years will present challenges and opportunities for psycho-oncology to improve care for patients.

The articles in Part I of this Special Report discuss PTSD in cancer, special issues for patients with schizophrenia and cancer, and distress management.

Michelle Riba, MD, shares her thoughts on the days ahead.

We psychiatrists can't solve the world's political problems, but we can help those who are affected by them. Suggestions here.

College mental health is not just a matter of identifying problems but also of creating a community of students, families, friends, mental health professionals, faculty advisors, and many others to help students gain psychological resiliency.

When I ask friends and colleagues about this book, most of them have really enjoyed it and would love to discuss it with me if I let them . . . but I don’t want to. Here's why.

As with all medical emergencies, psychiatric emergencies are among the most clinically challenging situations.

Many of our female patients are more worried about breast cancer than heart disease. Because psychiatrists will almost certainly care for patients who have a history of breast cancer, Dr Riba reviews some of the major issues to consider.

There is no question that psychotherapy and psychopharmacology can be successfully integrated. Indeed, there are still many psychiatrists left in this country who talk to patients and families, provide both psychotherapy and psychopharmacology, and care for patients in a biopsychosocial context.